Microbio Co (ROCO:4128) Operating Income: NT$-467 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4128 Microbio Co Ltd ROCO:4128
56 GF Score
Price NT$15.10
GF Value NT$36.97
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Microbio Co Operating Income?

Microbio Co ROCO:4128 56 Operating Income is NT$-467 Mil as of Jun. 2026. GuruFocus rates ROCO:4128 with a GF Score™ of 56/100 and a GF Value™ of NT$36.97 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Microbio Co's Operating Income for the three months ended in Jun. 2026 was NT$-154 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-467 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Microbio Co's Operating Income for the three months ended in Jun. 2026 was NT$-154 Mil. Microbio Co's Revenue for the three months ended in Jun. 2026 was NT$479 Mil. Therefore, Microbio Co's Operating Margin % for the quarter that ended in Jun. 2026 was -32.08%.

Good Sign:

Microbio Co Ltd operating margin is expanding. Margin expansion is usually a good sign.

Microbio Co's 5-Year average Growth Rate for Operating Margin % was 20.20% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Microbio Co's annualized ROC % for the quarter that ended in Jun. 2026 was -6.60%. Microbio Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 167.80%.


Microbio Co  (ROCO:4128) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Microbio Co's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=-614.94 * ( 1 - 0% )/( (8917.312 + 9718.789)/ 2 )
=-614.94/9318.0505
=-6.60 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=12026.764 - 363.788 - ( 2830.738 - max(0, 576.81 - 3322.474+2830.738))
=8917.312

Invested Capital(Q: Jun. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=12829.815 - 330.371 - ( 2837.403 - max(0, 548.126 - 3328.781+2837.403))
=9718.789

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Microbio Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3012.548/( ( (1724.201 + max(24.941000000001, 0)) + (1787.848 + max(53.586, 0)) )/ 2 )
=3012.548/( ( 1749.142 + 1841.434 )/ 2 )
=3012.548/1795.288
=167.80 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(52.67 + 256.399 + 143.601) - (363.788 + 0 + 63.941)
=24.941000000001

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(40.038 + 249.424 + 159.974) - (330.371 + 0 + 65.479)
=53.586

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Microbio Co's Operating Margin % for the quarter that ended in Jun. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-153.735/479.284
=-32.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Microbio Co Operating Income Related Terms


Microbio Co Operating Income Historical Data

* Premium members only.

The historical data trend for Microbio Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbio Co Operating Income Chart

Microbio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,161.37 -278.85 -505.50 -451.14 -406.62

Microbio Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -126.92 -102.63 -96.36 -114.37 -153.74
ROCO:4128
56GF Score
Microbio Co Ltd ROCO:4128
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbio Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-467 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of NT$-467 Mil mean?
Microbio Co (ROCO:4128) has a Operating Income of NT$-467 Mil as of Jun. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Microbio Co and its competitors.
Is Microbio Co's Operating Income too high?
Microbio Co's current Operating Income is NT$-467 Mil. Overall, Microbio Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Microbio Co's Operating Income compare to KHC and GIS?
Microbio Co's Operating Income of NT$-467 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Consumer Packaged Goods company?
A good Operating Income depends on the Consumer Packaged Goods industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Microbio Co and its competitors. Microbio Co's current Operating Income is NT$-467 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbio Co stock overvalued right now?
Based on GuruFocus' analysis, Microbio Co (ROCO:4128) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$36.97, compared to a current price of NT$15.10 — trading 59.2% below its estimated fair value. The current Operating Income is NT$-467 Mil. Microbio Co's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Microbio Co (ROCO:4128), the current Operating Income is NT$-467 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbio Co (ROCO:4128) Overvalued in 2026?

Based on GuruFocus' analysis, Microbio Co stock appears to be undervalued. The current stock price of NT$15.10 is trading 59.2% below its estimated GF Value™ of NT$36.97. GuruFocus considers Microbio Co to be Significantly Undervalued.

Key valuation signals for ROCO:4128:

  • Operating Income: NT$-467 Mil
  • GF Value™: NT$36.97 vs. price of NT$15.10 (59.2% below fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Microbio Co Business Description

Address Yuanqu Street, No. 3, 18th Floor - 1, Sanchong Village, Nangang District, Taipei, TWN
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
56GF Score

Get the complete analysis for ROCO:4128

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.10
Price
NT$36.97
GF Value